| 发明名称 |
MODIFIED RELEASE FORMULATION. |
| 摘要 |
Drug products in the form of modified release formulations comprising the drug substance (-)-(3aR,4S,7aR)-4-Hydroxy-4m-tolylethynyl-octahydro-indole-1-c arboxylic acid methyl ester (AFQ056), as well as processes for making such drug products are 5 provided. The drug products are useful in treating patients with Parkinson's disease and exhibiting L-dopa induced dyskinesia. |
| 申请公布号 |
MX2015017202(A) |
申请公布日期 |
2016.11.11 |
| 申请号 |
MX20150017202 |
申请日期 |
2014.06.11 |
| 申请人 |
NOVARTIS AG |
发明人 |
Arnaud GRANDEURY;Mike UFER;Bruno GALLI;Hubert THOMA;Dirk SPICKERMANN;Karsten PUTZBACH;Martin MUELLER- ZSIGMONDY;Klaus- Peter MOLL;Jean- Marie GLANTZMANN |
| 分类号 |
A61K31/404;A61J3/02;A61J3/10;A61K9/16;A61K9/20;A61K9/50;A61K47/38 |
主分类号 |
A61K31/404 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
